BXRX - Spark Newswire

2 minute read

Baudax Bio Announces 1-for-40 Reverse Stock Split

Today, 12:08 PM

Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on innovative products for hospital and related settings, today announced that the Company's Board of Directors has approved a 1-for-40 reverse stock

BXRX

5 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 12:08 PM

On Monday, 79 companies reached new 52-week lows.

ADCT

10 minute read

News
Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 12:08 PM

During Tuesday's trading, 160 companies set new 52-week lows.

ABSI

1 minute read

News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights

Today, 12:08 PM

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies…

BXRX

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 12:08 PM

On Wednesday, 283 companies set new 52-week lows.

ACHL

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 12:08 PM

Gainers

ATHX

1 minute read

Baudax Bio Q3 EPS $(2.47) Up From $(7.00) YoY

By Benzinga Newsdesk

Today, 12:08 PM

Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(2.47) per share. This is a 64.71 percent increase over losses of $(7.00) per share from the same period last year.

BXRX

3 minute read

Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket

By Lisa Levin

Today, 12:08 PM

Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.

ABNB